WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy - 2000 - 2003
(2000; 81 pages) [French] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoAbbreviations, Acronyms & WHO Regions
Ver el documentoHighlights - WHO Medicines Strategy: 2000 - 2003
Abrir esta carpeta y ver su contenido1. The Impact of Essential Drugs
Abrir esta carpeta y ver su contenido2. Strategic Directions
Ver el documento3. Core Functions Improving Health Through Knowledge, Advocacy and Partnership
Abrir esta carpeta y ver su contenido4. Country Work - Why and How?
Abrir esta carpeta y ver su contenido5. Framework for Action: Objectives and Expected Outcomes for 2000 - 2003
Cerrar esta carpeta6. Monitoring Progress
Ver el documento6.1 Monitoring, evaluation and indicators
Ver el documento6.2 Country progress indicators for the WHO Medicines Strategy
Ver el documento6.3 Indicator values for the WHO Medicines Strategy
Ver el documento6.4 Improving the monitoring/evaluation process and tools
Ver el documentoReferences and Notes
 

6. Monitoring Progress

“Monitoring is an integral part of day-to-day management in successful drug programs. Systematic monitoring, based on program objectives and linked to specific activities, is essential for improving program performance and achieving long-term program goals.”

Management Sciences for Health/World Health Organization, 1997. 50

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 19 enero 2012